Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Andexanet-alfa/apixaban

Intracranial haemorrhage and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Blackburn M. Four-factor prothrombin complex concentrate administration after expanding intracranial hemorrhage status post administration of andexanet alfa. American Journal of Emergency Medicine 62: 144.e1-144.e3, Dec 2022. Available from: URL: /link?doi=10.1016/j.ajem.2022.08.041 Blackburn M. Four-factor prothrombin complex concentrate administration after expanding intracranial hemorrhage status post administration of andexanet alfa. American Journal of Emergency Medicine 62: 144.e1-144.e3, Dec 2022. Available from: URL: /link?doi=10.1016/j.ajem.2022.08.041
Metadaten
Titel
Andexanet-alfa/apixaban
Intracranial haemorrhage and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41293-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Multiple drugs